Laddar…
USP22 upregulates ZEB1-mediated VEGFA transcription in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a common solid tumor with high rate of recurrence and mortality. Anti-angiogenesis drugs have been used for the therapy of HCC. However, anti-angiogenic drug resistance commonly occurs during HCC treatment. Thus, identification of a novel VEGFA regulator would be be...
Huvudupphovsmän: | , , , , , , , , , , , , , , , , |
---|---|
Materialtyp: | Online Artikel Text |
Språk: | English |
Publicerad: |
Nature Publishing Group UK
2023
|
Ämnen: | |
Länkar: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008583/ https://www.ncbi.nlm.nih.gov/pubmed/36906615 http://dx.doi.org/10.1038/s41419-023-05699-y |